genedrive plc
("genedrive" or the "Company")
Block Listing Six Monthly Return
|
Name of applicant |
genedrive plc |
|||
|
Name of scheme |
2007 Share Option Scheme |
|||
|
Period of return: |
From: |
28 May 2022 |
To: |
30 November 2022 |
|
Balance of unallocated securities under scheme(s) from previous return: |
139,226 shares |
|||
|
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
Nil |
|||
|
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): |
Nil |
|||
|
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
139,226 shares |
|||
|
Name of contact: |
Russ Shaw CFO |
|
Telephone number of contact: |
+44 (0)161 989 0245 |
For enquires:
|
genedrive plc |
+44 (0)161 989 0245 |
|
|
David Budd: CEO / Russ Shaw: CFO |
||
|
Peel Hunt LLP (Nominated Adviser and Joint Broker) |
+44 (0)20 7418 8900 |
|
|
James Steel / Oliver Duckworth |
||
|
finnCap (Joint Broker) |
+44 (0)20 7220 500 |
|
|
Geoff Nash / George Dollemore / Nigel Birks / Alice Lane |
||
|
Walbrook PR Ltd (Media Relations & Investor Relations) |
+44 (0)20 7933 8780 or genedrive@walbrookpr.com |
|
|
Paul McManus / Anna Dunphy |
+44 (0)7980 541 893 / +44 (0)7876 741 001 |
|